Chalinee Monsereenusorn, Kunanya Suwannaying, Jassada Buaboonnam, Lalita Sathitsamitphong, Piti Techavichit, Samart Pakakasama, Su-On Chainansamit, Usanarat Anurathapan, Patcharee Komvilaisak, Chanchai Traivaree, Kleebsabai Sanpakit, Pimlak Charoenkwan, Panya Seksarn
BACKGROUND: Disease reactivation/refractory remains a major challenge in managing Langerhans cell histiocytosis (LCH). Outcomes and late sequelae should be explored. METHODS: A multi-institutional retrospective study was conducted to describe clinical characteristics, predictive factors, outcomes and late sequelae of pediatric reactivation/refractory LCH in Thailand. RESULTS: In all, 47 patients were studied, 25 (53.2%) patients had disease reactivation and 22 (46...
May 1, 2024: Asian Pacific Journal of Cancer Prevention: APJCP